Motixafortide
Product Sizes
25 mg
£ POA
HY-P0171-25MG
10 mg
£ POA
HY-P0171-10MG
5 mg
£ POA
HY-P0171-5MG
50 mg
£ POA
HY-P0171-50MG
100 mg
£ POA
HY-P0171-100MG
About this Product
- SKU:
- HY-P0171
- Additional Names:
- BKT140 (4-fluorobenzoyl); BL-8040; TF14016
- Application:
- Antibody Microarray
- CAS Number:
- 664334-36-5
- Extra Details:
- Motixafortide (BKT140 4-fluorobenzoyl) is a novel CXCR4 antagonist with an IC50 vakue of ～1 nM.
- Molecular Weight:
- 2159.52
- Purity:
- 99.76
- References:
- [1]Peled A, et al. The high-affinity CXCR4 antagonist BKT140 is safe and induces a robust mobilization of human CD34+ cellsin patients with multiple myeloma. Clin Cancer Res. 2014 Jan 15;20(2):469-79.|[2]Beider K, et al. CXCR4 antagonist 4F-benzoyl-TN14003 inhibits leukemia and multiple myeloma tumor growth. Exp Hematol. 2011 Mar;39(3):282-92.
- Research Area:
- Cancer; Endocrinology
- Shipping Conditions:
- Blue Ice
- Storage Conditions:
- -80[o]C; 2 years; -20[o]C; 1 year (Powder; sealed storage; away from moisture)
- Type:
- Proteins, Peptides, Small Molecules & Other Biomolecules: Peptides
- Pathway:
- GPCR/G Protein;Immunology/Inflammation
